Jill Fallows Macaluso Esq., RN, has been Corporate Vice President and
Chief Compliance Officer for Novo Nordisk Inc. since January 2018 and
has been leading the US Compliance Program since being appointed Vice
President and Chief Compliance Officer in September 2015. Ms. Fallows
Macaluso is responsible for safeguarding corporate governance and
integrity practices in the United States while upholding the company's
commitment to operate according to the highest ethical standards of
business conduct as part of the Novo Nordisk Way.
With 15 years of industry experience, Ms. Fallows Macaluso has
been instrumental in evolving Novo Nordisk's compliance program to
support industry leading business practices. By serving as a
corporate compliance partner, she has spearheaded efforts focused on
rebranding and operational efficiency. As chair of the Executive
Ethics & Compliance Committee, she plays an active role ensuring
compliance is incorporated into company decision-making processes.
Ms. Fallows Macaluso joined Novo Nordisk in 2003 and held
several positions of escalating responsibility with in the Legal
Team for nine years including Senior Corporate Counsel. She
transitioned to the Compliance Department as Senior Director in 2012.
Previously, Ms. Fallows Macaluso was with the General
Corporate and Healthcare practice of Day Pitney, LLP. She holds a
Bachelor of Science in Nursing from the University of Pennsylvania
and a Juris Doctorate from Rutgers University School of Law.